IRCT20161206031255N4 IRCT 2020-12-07 Shahid Beheshti University of Medical Sciences ٍEfficacy of prebiotic products on admitted patients with Covid-19 Evaluation of probiotic use on control of sign and symptoms of admitted patients with covid-19 2020-09-22 anticipated 60 Complete https://irct.ir/trial/50229 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Initially, before starting the sampling, the row number from 1 to 60 is considered for all patients. Then, with the software SPSS, half of the numbers are randomly given to the patient group and the other half to the control. As soon as the patient enters the study, the row number is considered in the list in the order of entry. Grouping was done based on predetermined numbers. 3 covid 19. Intervention 1: Intervention group: Patients take standard medicine hydroxychlroquine and remdecevir. prebiotic powder 150 mg in the pack that 3 mg per dose for three times a day for 2 weeks. Intervention 2: Control group: hydroxychlroquin and remdecevir as standard treatment. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is not more information.